EW News and Press, Edwards Lifesciences Corporation From 06/28/22

Wedgewood Partners’ 13F portfolio value decreased from ~$753M to $709M this quarter. They increased Meta Platforms, Taiwan Semi, and PayPal while reducing Alphabet and Keysight Technologies. Their top five positions are at 38% of the overall portfolio. For further det...

Edwards Lifesciences is reporting high growth rates and the market could double until 2028. Considering what might come (potential recession and bear market), it is good to know that Edwards Lifesciences is more or less recession-proof. However, Edwards Lifesciences still seems to...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Edwards Lifesciences is well positioned to absorb cost headwinds in the medical technology segment. The company's propensity to drive free cash flow below the bottom line has ensured a robust schedule of growth in earnings and equity value. Recent pullbacks to its share price only...

EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE PR Newswire IRVINE, Calif. , May 23, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernst...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022 PR Newswire PARIS , May 16, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced key events for the company during EuroPCR 2022, the annual meeting of the European Association of Per...

Healthcare equipment and Medical Devices sector stood out during the covid-19 pandemic crisis and delivered strong returns over the medium and long term. Stocks from healthcare equipment and Medical Devices sector have performed poorly over the past one month, resulting in steep price...

Investors bailed out of tech and growth stocks even as tech insiders added more. Insider buying on the XLK ETF has surged to the highest in the last ten years. We discuss why the bottoming in tech and growth stocks could be forming. Subsequently, we believe the outperformance in growt...

The release of Shockwave C² is a similar event to TAVRs for Edwards Lifesciences. Considering the cardiovascular industry tailwinds, the unique niche in calcified stenosis, and safety profile should allow a similar growth trajectory for SWAV. A tremendous earnings report...